2004
DOI: 10.1016/j.vaccine.2004.01.041
|View full text |Cite
|
Sign up to set email alerts
|

Persistence of protective immunity following vaccination against tick-borne encephalitis—longer than expected?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
0
3

Year Published

2006
2006
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(22 citation statements)
references
References 18 publications
2
17
0
3
Order By: Relevance
“…Due to the fact that there is no specific antiviral agent available to treat TBE, prevention is the most important measure to diminish the individual as well as the public health impact of TBEV. Although in the vast majority of vaccinated individuals immunity persists for more than 3 years after a complete course of three vaccinations, about 7% of individuals older than 50 years show titers of neutralizing antibodies below 1:10 after 3 years, which calls their immunity into question [11]. Since the optimal time schedule for booster immunizations after complete or incomplete primary immunization is not known, currently large longitudinal prospective studies are conducted.…”
Section: Discussionmentioning
confidence: 99%
“…Due to the fact that there is no specific antiviral agent available to treat TBE, prevention is the most important measure to diminish the individual as well as the public health impact of TBEV. Although in the vast majority of vaccinated individuals immunity persists for more than 3 years after a complete course of three vaccinations, about 7% of individuals older than 50 years show titers of neutralizing antibodies below 1:10 after 3 years, which calls their immunity into question [11]. Since the optimal time schedule for booster immunizations after complete or incomplete primary immunization is not known, currently large longitudinal prospective studies are conducted.…”
Section: Discussionmentioning
confidence: 99%
“…Studies on the persistence of antibodies after primary immunization with the conventional or rapid schedule and booster doses have shown higher titres in the younger adults when compared with the elderly (Beran et al, 2004;Rendi-Wagner et al, 2004b;Zent et al, 2004a). The GMTs (measured by ELISA or NT) before booster were lower in the elderly, and although the titre increase was higher for the elderly than for the younger adults, the post-booster GMTs were still higher for the younger adults (Beran et al, 2004;RendiWagner et al, 2004b).…”
Section: Article In Pressmentioning
confidence: 99%
“…The present study is thus the first to offer robust data demonstrating that antibody persistence following complete primary vaccination (either conventional or accelerated conventional schedule) with Encepur ® Children alone lasts for up to 5 years. While longer than expected antibody persistence (>3 years) has been reported in adults following primary immunization with three doses of FSME-IMMUN ® [21], this was not demonstrated in children receiving a mixed primary immunization series with FSME-IMMUN ® Junior and Encepur ® Children (two doses of FSME-IMMUN ® Junior and one dose of Encepur ® Children). The Encepur ® results, however, are in line with previous reports in both children and adults that have shown persistence of antibody responses for up to 5 years following booster vaccinations with Encepur ® [8,11,22,23].…”
Section: Discussionmentioning
confidence: 74%